Product image of Lamisil Dermgel (Terbinafine) supplied by GNH India

Lamisil Dermgel

Active Ingredient:
Terbinafine
Origin:
EU

Lamisil Dermgel (Terbinafine)

Terbinafine, the active ingredient in Lamisil Dermgel, is an allylamine antifungal presented as a gel for topical use. It is designed to treat superficial dermatophyte infections such as athlete's foot, ringworm and jock itch in both adults and children, delivering high drug concentrations directly to the skin.

GNH India supplies Lamisil Dermgel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with European Union pharmacopeial specifications and is manufactured under GMP conditions, ensuring consistent quality.

Manufacturer / TM Owner

Karo Healthcare Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Terbinafine is an allylamine antifungal used to treat superficial dermatophyte infections of the skin.

  • Tinea pedis (athlete's foot): Reduces fungal growth and alleviates itching, scaling and redness on the feet.
  • Tinea corporis (ringworm): Clears the fungal infection on the body, promoting healing of lesions.
  • Tinea cruris (jock itch): Eliminates the causative fungus and relieves irritation in the groin area.

How It Works

  • Terbinafine inhibits the fungal enzyme squalene epoxidase, blocking the conversion of squalene to ergosterol. This disruption impairs ergosterol synthesis, a critical component of fungal cell membranes, leading to accumulation of toxic squalene and loss of membrane integrity, which ultimately kills the fungus.

Side Effects

Terbinafine gel may cause local adverse reactions.

Common Side Effects

  • Application site irritation: mild burning or stinging sensation.
  • Redness or erythema at the site of application.
  • Itching or pruritus localized to the treated area.
  • Dryness or peeling of the skin.
  • Mild rash confined to the area of use.
  • Sensation of warmth or tingling.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, hives, or difficulty breathing.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Generalized contact dermatitis extending beyond the application site.
  • Systemic toxicity such as liver enzyme elevation (rare with topical use).

Precautions & Warnings

Before using Lamisil Dermgel, consider the following precautions:

  • Avoid use on extensive broken or inflamed skin: limit application to intact epidermis.
  • Do not apply to mucous membranes or eyes: avoid accidental contact.
  • Monitor for signs of allergic reaction: discontinue if severe rash or swelling occurs.
  • Use with caution in patients with known liver disease: systemic absorption is minimal but monitor if large areas are treated.
  • Keep out of reach of children: accidental ingestion may cause systemic effects.
  • Store at ambient temperature: keep the tube tightly closed, protect from light and moisture.

Avoid Interactions

Terbinafine gel has limited systemic interactions, but consider the following:

Major Interactions (Avoid)

  • Concurrent systemic terbinafine therapy: may increase total exposure and risk of systemic toxicity.
  • Use with other topical antifungal agents containing azoles: can increase local irritation.

Moderate Interactions (Monitor Closely)

  • Application together with potent corticosteroid creams: may mask early signs of irritation.
  • Use with skin irritants (e.g., chemical peels): could exacerbate local reactions.
  • Combination with other topical agents that alter skin barrier: monitor for increased absorption.

Frequently Asked Questions

Lamisil Dermgel is a topical gel containing the antifungal terbinafine. It is indicated for the treatment of superficial dermatophyte infections such as athlete's foot (tinea pedis), ringworm (tinea corporis) and jock itch (tinea cruris). The gel is applied directly to the affected skin to eradicate the fungus and relieve symptoms.

Terbinafine works by inhibiting the fungal enzyme squalene epoxidase, which is essential for the synthesis of ergosterol, a key component of fungal cell membranes. Blocking this pathway leads to accumulation of toxic squalene and loss of membrane integrity, causing fungal cell death.

The prescribed dose is determined by the treating clinician. Typically, a thin layer of the gel is applied once daily to the clean, dry affected area for a period specified by the prescriber, which may range from one to four weeks depending on the infection.

Safety data for topical terbinafine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any necessary import documentation.

Compared with azole‑based creams such as clotrimazole or miconazole, terbinafine has a fungicidal mechanism and often achieves cure in a shorter treatment duration. It penetrates the skin effectively and is less prone to resistance, making it a preferred option for many dermatophyte infections.

Store the gel at ambient temperature, ideally below 25 °C. Keep the tube tightly closed, protect it from direct light and moisture, and store it out of reach of children. No refrigeration is required.

Clean and dry the affected skin area, then apply a thin layer of the gel and gently rub it in. Wash your hands after application unless the hands are the treatment site. Follow the prescriber's instructions regarding frequency and duration of use.

Although rare, serious adverse reactions can include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and generalized contact dermatitis. If any signs of a severe skin reaction or systemic symptoms appear, discontinue use and seek medical attention immediately.

Individuals with a known hypersensitivity to terbinafine, other allylamine antifungals, or any component of the formulation should avoid using the gel. It is also contraindicated on large areas of broken or inflamed skin where systemic absorption could be increased.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.